Donor assessment scores: Relevance and complete irrelevance

Liver Transplantation

Volumn 18, Issue SUPPL.2, 2012, Pages

  Porrett, Paige M ^a   Ter Horst, Matthijs ^a   Shaked, Abraham ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BODY MASS; CLINICAL ASSESSMENT TOOL; DONOR; DONOR ASSESSMENT SCORE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMPLANT REGISTRY; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SURVIVAL OUTCOMES FOLLOWING LIVER TRANSPLANTATION;

DONOR SELECTION; END STAGE LIVER DISEASE; HUMANS; LIVER TRANSPLANTATION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 84868149045     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23504     Document Type: Article

References (16)

1. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
2. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM,. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-425.
3. Maluf DG, Edwards EB, Kauffman HM,. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the Model for End-Stage Liver Disease Score of the recipient? Transplantation 2006; 82: 1653-1657.
4. Blok JJ, Braat AE, Adam R, Burroughs AK, Putter H, Kooreman NG, et al.; for European Liver Intestine Transplant Association and Eurotransplant Liver Intestine Advisory Committee. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl 2012; 18: 112-119.
5. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson JB, Yeh MM, et al. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment. Liver Transpl 2010; 16: 874-884.
6. Briceño J, Padillo J, Rufián S, Solõrzano G, Pera C,. Assignment of steatotic livers by the Mayo Model for End-Stage Liver Disease. Transpl Int 2005; 18: 577-583.
7. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004; 230: 276-280.
8. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537-2546.
9. Dutkowski P, Oberkofler CE, Slankamenac K, Puhan MA, Schadde E, Müllhaupt B, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the Model for End-Stage Liver Disease era. Ann Surg 2011; 254: 745-753.
10. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD,. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9: 318-326.
11. Vitale A, Ramirez Morales R, dalla Bona E, Scopelliti M, Zanus G, Neri D, et al. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. Transplant Proc 2011; 43: 974-976.
12. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, et al. Predicting outcome after liver transplantation: utility of the Model for End-Stage Liver Disease and a newly derived discrimination function. Transplantation 2004; 77: 99-106.
13. Trotter JF, Osgood MJ,. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-1874.
14. 1H NMR spectroscopy. Anal Chem 2005; 77: 5570-5578.
15. Friedman BH, Wolf JH, Wang L, Putt ME, Shaked A, Christie JD, et al. Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl 2012; 18: 166-176.
16. de Jonge J, Kurian S, Shaked A, Reddy KR, Hancock W, Salomon DR, Olthoff KM,. Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. Am J Transplant 2009; 9: 758-772.